BioSante soars on study; drug stocks slip (at MarketWatch)
March 11, 2010
Shares of BioSante Pharmaceuticals Inc. soared 16% in early action Thursday, powered by a study that showed its GVAX vaccine appeared to be effective in batting chronic myeloid leukemia, or CML.
Lesen hier die vollständige Nachricht
Kommentarer



